In This Section

Research Funding Impact

Since 1993, the AACR has awarded more than $480 million in grants to fund meritorious research projects across the spectrum of cancer science, including basic, translational, and clinical research. See how the AACR grants program has contributed to the AACR's mission.

Search/Filter
Loading...
AACR-Bristol Myers Squibb Midcareer Female Investigator Grants: Closing Funding Gaps and Expanding Research

AACR-Bristol Myers Squibb Midcareer Female Investigator Grants: Closing Funding Gaps and Expanding Research

The AACR-Bristol Myers Squibb Midcareer Female Investigator Grant is the AACR’s first dedicated funding mechanism for midcareer scientists, as well as the first dedicated for women. The goal is to ensure that midcareer female researchers have the resources they need to successfully establish themselves as independent investigators with productive research labs.

When a Grant Means “More than Money”

When a Grant Means “More than Money”

Kimberly Kelly, PhD, the CEO of a biotech startup called ZielBio, received an AACR-PanCAN Career Development Award for Pancreatic Cancer Research as one of the first grants of her independent academic career. The value of the grant, she says, is more than the money.

SU2C-Lustgarten Foundation Pancreatic Cancer Dream Team Shows that Treating CRC and PDA Patients with CXCR4 Inhibitor Effectively Elicits an Integrated Immune Response

SU2C-Lustgarten Foundation Pancreatic Cancer Dream Team Shows that Treating CRC and PDA Patients with CXCR4 Inhibitor Effectively Elicits an Integrated Immune Response

The SU2C-Lustgarten Foundation Pancreatic Cancer Dream Team set out in 2014 to develop immune-based therapeutic strategies for pancreatic ductal adenocarcinoma (PDA). Their efforts were spurred by the underlying hypothesis that the immunosuppressive PDA milieu could be reprogrammed into an immuno-stimulatory one capable of tumor rejection, thus converting PDA into a treatable disease.

New Club Allows AACR Grantees to Meet – Virtually

New Club Allows AACR Grantees to Meet – Virtually

As the coronavirus pandemic continues to ravage the world, conferences and meetings worldwide are being canceled or moved to virtual mode. This loss of in-person interactions has significantly reduced the number of opportunities for researchers to share ideas, present research, learn career advancement skills, and establish connections with peers, colleagues, and potential collaborators.

Dr. Carsten Hagemann on AACR-Novocure TTFields Research Grant Impact

Dr. Carsten Hagemann on AACR-Novocure TTFields Research Grant Impact

The AACR-Novocure Tumor Treating Fields Research Grants represent a joint effort to promote and support innovative research focused on Tumor Treating Fields (TTFields), which are intermediate frequency, low intensity, alternating electric fields that disrupt cell division in cancer cells. 2020 grant recipient Carsten Hagemann, PhD, shares his perspectives on the myriad benefits of the grant.